Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care
Trial Parameters
Brief Summary
The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs. 50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.
Eligibility Criteria
Inclusion Criteria: * Women aged ≥18 years * Gestational age 32+0 weeks onwards. * Singleton pregnancy. * Able to speak English * Receiving antenatal care which includes routine antenatal fetal monitoring for one of the 6 index conditions (hypertensive disease in pregnancy, reduced fetal growth (small for gestational age and fetal growth restriction) obstetric cholestasis, PPROM, previous history of stillbirth and recurrent reduced fetal movements ) * Able to give written informed consent. * Willing to attend hospital immediately in the event of an unexpected finding whilst using the home devices. Exclusion Criteria: * Multiple pregnancy. * Fetal abnormalities or a non-viable fetus. * Body mass index (BMI) ≥35 * Women with internal cardiac devices such as pacemaker and implantable cardioverter defibrillator. * History of allergic reaction to skin adhesives and/or latex. * Acute or chronic skin lesions and wounds in areas in contact with the device.